Literature DB >> 19343484

Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.

Andrea Hawe1, Robert Poole, Stefan Romeijn, Piotr Kasper, Rob van der Heijden, Wim Jiskoot.   

Abstract

PURPOSE: To investigate degradation kinetics of oxytocin as a function of temperature and pH, and identify the degradation products.
MATERIALS AND METHODS: Accelerated degradation of oxytocin formulated at pH 2.0, 4.5, 7.0 and 9.0 was performed at 40, 55, 70 and 80 degrees C. Degradation rate constants were determined from RP-HPLC data. Formulations were characterized by HP-SEC, UV absorption and fluorescence spectroscopy. Degradation products were identified by ESI-MS/MS.
RESULTS: The loss of intact oxytocin in RP-HPLC was pH- and temperature-dependent and followed (pseudo) first order kinetics. Degradation was fastest at pH 9.0, followed by pH 7.0, pH 2.0 and pH 4.5. The Arrhenius equation proved suitable to describe the kinetics, with the highest activation energy (116.3 kJ/mol) being found for pH 4.5 formulations. At pH 2.0 deamidation of Gln(4), Asn(5), and Gly(9)-NH2, as well as combinations thereof were found. At pH 4.5, 7.0 and 9.0, the formation of tri- and tetrasulfide-containing oxytocin as well as different types of disulfide and dityrosine-linked dimers were found to occur. Beta-elimination and larger aggregates were also observed. At pH 9.0, mono-deamidation of Gln(4), Asn(5), and Gly(9)-NH2 additionally occurred.
CONCLUSIONS: Multiple degradation products of oxytocin have been identified unequivocally, including various deamidated species, intramolecular oligosulfides and covalent aggregates. The strongly pH dependent degradation can be described by the Arrhenius equation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343484      PMCID: PMC2689356          DOI: 10.1007/s11095-009-9878-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.

Authors:  K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Dityrosine: preparation, isolation, and analysis.

Authors:  D A Malencik; J F Sprouse; C A Swanson; S R Anderson
Journal:  Anal Biochem       Date:  1996-11-15       Impact factor: 3.365

Review 3.  Induction of labour at the start of the new millennium.

Authors:  I Z Mackenzie
Journal:  Reproduction       Date:  2006-06       Impact factor: 3.906

4.  Sequence and structure determinants of the nonenzymatic deamidation of asparagine and glutamine residues in proteins.

Authors:  H T Wright
Journal:  Protein Eng       Date:  1991-02

Review 5.  Secondary structure and protein deamidation.

Authors:  M Xie; R L Schowen
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

6.  Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR data.

Authors:  R J Turner; J M Matsoukas; G J Moore
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

7.  Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms.

Authors:  F A Chaibva; R B Walker
Journal:  J Pharm Biomed Anal       Date:  2006-08-22       Impact factor: 3.935

8.  Synthesis and pharmacology of novel analogues of oxytocin and deaminooxytocin: directed methods for the construction of disulfide and trisulfide bridges in peptides.

Authors:  L Chen; I Zoulíková; J Slaninová; G Barany
Journal:  J Med Chem       Date:  1997-03-14       Impact factor: 7.446

9.  Confirmation by mass spectrometry of a trisulfide variant in methionyl human growth hormone biosynthesized in Escherichia coli.

Authors:  E Canova-Davis; I P Baldonado; R C Chloupek; V T Ling; R Gehant; K Olson; B L Gillece-Castro
Journal:  Anal Chem       Date:  1996-11-15       Impact factor: 6.986

10.  Detection of traces of a trisulphide derivative in the preparation of a recombinant truncated interleukin-6 mutein.

Authors:  J Breton; N Avanzi; B Valsasina; L Sgarella; A La Fiura; U Breme; G Orsini; E Wenisch; P G Righetti
Journal:  J Chromatogr A       Date:  1995-08-11       Impact factor: 4.759

View more
  21 in total

1.  Characterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77.

Authors:  David F Nellis; Dennis F Michiel; Man-Shiow Jiang; Dominic Esposito; Richard Davis; Hengguang Jiang; Angela Korrell; George C Knapp; Lauren E Lucernoni; Roy E Nelson; Emily M Pritt; Lauren V Procter; Mark Rogers; Terry L Sumpter; Vinay V Vyas; Timothy J Waybright; Xiaoyi Yang; Amy M Zheng; Jason L Yovandich; John A Gilly; George Mitra; Jianwei Zhu
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

Review 2.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 3.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

4.  A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.

Authors:  Christina Avanti; Jean-Pierre Amorij; Dewi Setyaningsih; Andrea Hawe; Wim Jiskoot; Jan Visser; Alexej Kedrov; Arnold J M Driessen; Wouter L J Hinrichs; Henderik W Frijlink
Journal:  AAPS J       Date:  2011-03-30       Impact factor: 4.009

5.  Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.

Authors:  Karine Fabio; Kieran Curley; Joseph Guarneri; Benoit Adamo; Brendan Laurenzi; Marshall Grant; Robin Offord; Kelly Kraft; Andrea Leone-Bay
Journal:  AAPS PharmSciTech       Date:  2015-03-17       Impact factor: 3.246

6.  Kinetics study of the natural split Npu DnaE intein in the generation of bispecific IgG antibodies.

Authors:  Huifang Zong; Lei Han; Jie Chen; Zhidi Pan; Lei Wang; Rui Sun; Kai Ding; Yueqing Xie; Hua Jiang; Huili Lu; John Gilly; Baohong Zhang; Jianwei Zhu
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-09       Impact factor: 4.813

Review 7.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

Review 8.  Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists.

Authors:  Beatrix Stadler; Michael R Whittaker; Betty Exintaris; Ralf Middendorff
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-22       Impact factor: 5.555

9.  Capillary electrophoresis separation of the desamino degradation products of oxytocin.

Authors:  Jessica S Creamer; Shannon T Krauss; Susan M Lunte
Journal:  Electrophoresis       Date:  2013-12-02       Impact factor: 3.535

10.  Analytical and physiological validation of an enzyme immunoassay to measure oxytocin in dog, wolf, and human urine samples.

Authors:  G Wirobski; F S Schaebs; F Range; S Marshall-Pescini; T Deschner
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.